Herbal medicine is not main cause of kidney disease – Expert
A medical expert has cautioned that while misuse of herbal medicines can contribute to kidney damage, they are…
Scientists Just Found Something Rather Grim That Happens When You Stop Taking GLP-1s
Sign up to see the future, today Can’t-miss innovations from the bleeding edge of science and tech Much…
90 FDC drug samples, including Paracetamol, found unapproved; regulator asks states to take action
NEW DELHI: The Drug Controller General of India (DCGI) has launched a nationwide crackdown on unapproved Fixed Dose…
Public Health Ministry rolls out three-phase plan to manage medicines as Middle East conflict drags on
Thailand’s Public Health Ministry is rolling out a three-phase plan to manage medicine supplies and healthcare services as…
Thai authorities warn of disruption to key medicine supplies, price hikes if Mid-East war drags on
BANGKOK – Thailand’s Public Health Ministry is rolling out a three-phase plan to manage medicine supplies and healthcare…
Report links ADHD drug shortage in US to global supply chain disruptions
A nationwide shortage of stimulant medications used to treat attention-deficit hyperactivity disorder (ADHD) may be rooted less in…
Woman Called Tacky For Expecting Reimbursement For An EpiPen
A woman named Chad reignited the never-ending debate about the cost of healthcare after sharing the pretty odd…
Demand for GLP-1 pills and shots surges, and not just for weight loss
Whether they’re using weekly shots or daily pills, more Americans than ever are turning to anti-obesity drugs to…
Diversify With These Health ETFs
The FDA recently approved higher-dose version of Novo Nordisk’s NVO obesity drug Wegovy, further expanding the drug giant’s footprint in…
Goodbye, injections. Hello, Wegovy pill! – Orange County Register
Little’s spectacular Winter Formal dress (Photo by Teri Sforza) It is with tremendous pride that we present to…
Diversify With These Health ETFs — TradingView News
The FDA recently approved higher-dose version of Novo Nordisk’s NVO obesity drug Wegovy, further expanding the drug giant’s footprint in…
Ozempic Goes Generic —But Not in the US
A drug that helped turn Novo Nordisk into Europe’s most valuable company is about to lose its…